Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-14T04:25:02.516Z Has data issue: false hasContentIssue false
  • English
  • Français

The Use of Mupirocin in Controlling Methicillin-Resistant Staphylococcus aureus

Published online by Cambridge University Press:  21 June 2016

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Infection Control & Hospital Epidemiology , Volume 11 , Issue 1 , January 1990 , pp. 11 - 12
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1990

References

1. Malouin, F., Bryan, LE. Modification of penicillin-binding proteins as mechanisms of resistance to beta-lactam antibiotics. Antimicrob Agents Chemother. 1986; 30:1–5.10.1128/AAC.30.1.1CrossRefGoogle Scholar
2. McDougal, LK, Thornsbery, C. The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. J Clin Mcrobiol. 1986; 23:832–839.10.1128/jcm.23.5.832-839.1986CrossRefGoogle ScholarPubMed
3. Morrison, AJ, Wenzel, Rl? Nosocomial urinary tract infections due to enterococcus. Arch Intern Med. 1986; 146:1549–1551.10.1001/archinte.1986.00360200111018CrossRefGoogle ScholarPubMed
4. Jervons, MP. ‘Celbenin’-resistant staphylococci. Brit Med J. 1961; 1:124–125.10.1136/bmj.1.5219.124-aCrossRefGoogle Scholar
5. Haley, RW, Hightower, AN, Khabbaz, RF, et al. The emergence of methicillin-resistant Staphylococcus aureus infections in the United States hospitals. Ann Intern Med. 1982; 97:297–308.10.7326/0003-4819-97-3-297CrossRefGoogle ScholarPubMed
6. Thomas, JC, Bridge, J, Waterman, S, Vogt, J, Kilman, L, Hancock, G. Transmission and control of methicillin-resistant Staphylococcus aureus in a skilled nursing facility. Infect Control Hosp Epidemiol. 1989; 10:106–110.10.2307/30105108CrossRefGoogle Scholar
7. Neu, HC: Overview of mechanisms of bacterial resistance. Diagn Microbiol InfectDis. 1989; 12(Suppl):109–116.10.1016/0732-8893(89)90122-3CrossRefGoogle ScholarPubMed
8. Casewell, MW, Hill, RLR. In vitro activity of mupirocin (pseudomonic acid) against clinical isolates of Staphylococcus aureus. J. Antimicrob Chemother. 1985; 15:523–531.10.1093/jac/15.5.523CrossRefGoogle ScholarPubMed
9. Casewell, MW, Hill, RLR. Mupirocin (pseudomonic acid)—a promising new topical antimicrobial agent. J Antimicrob Chemother. 1987; 19:1–5.10.1093/jac/19.1.1CrossRefGoogle ScholarPubMed
10. Hosoital Infection Society and British Society for Antimicrobial Chemotherapy. Guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect. 1986; 7:193–201.10.1016/0195-6701(86)90064-2CrossRefGoogle Scholar
11. Rahman, M, Nobel, WC, Cookson, B. Mupirocin-resistant Staphylococcus aureus. Lancet. 1987;2:387.10.1016/S0140-6736(87)92398-1CrossRefGoogle Scholar
12. Smith, GE, Kennedy, CT. Staphylococcus aureus resistant to mupirocin. J Antimicrob Chemother. 1988;21:141–142.CrossRefGoogle ScholarPubMed
13. Bitar, CM, Mayhall, CG, Lamb, VA, Bradshaw, TJ, Spadora, AC, Dalton, HF? Outbreak due to methicillin and rifampin resistant Staphylococcus aureus: epidemiology and eradication of the resistant strain from the hospital. Intfect Control. 1987;8:15–23.10.1017/S0195941700066935CrossRefGoogle ScholarPubMed